Originally published September 23, 2007 at 12:00 AM | Page modified September 23, 2007 at 2:05 AM
Yours in Health
One more hearty cheer for pomegranate
Q: Could you talk more about whether pomegranate is also good for heart disease? I heard that it helps open up blocked arteries. Is that true? A:...
![]() |
Special to The Seattle Times
Q: Could you talk more about whether pomegranate is also good for heart disease? I heard that it helps open up blocked arteries. Is that true?
A: Thanks for your question. Here goes part two of the pomegranate story...
A lot of people have heard about using pomegranate for heart disease because of a study published in the American Journal Cardiology two years ago. In that study, 45 patients with heart disease and ischemia (ischemia means that they had trouble getting good circulation to their hearts) drank either 3 cups of pomegranate juice or a flavored drink for three months.
They got scans to check the blood flow to their hearts before and after. The people who drank pomegranate juice had better blood flow to their hearts on the scans. In contrast, the people who drank the flavored beverage didn't just stay the same — they actually had worse blood flow, despite the fact that everyone had stable blood pressure, blood sugar and medications.
The caveat to this study is that it was small. Otherwise, I think it was well designed, and the results are interesting. The results seem to go along with another study I want to tell you about.
In 2004, researchers took 10 people with plaque buildup in their carotid arteries. The nice thing about the carotid arteries (other than that they help your brain to get blood so you can think) is that they are located in the neck. This makes it easy to measure how much plaque they have using a simple sound-wave probe.
These 10 people drank pomegranate juice for one year, and the thickness of the plaque dropped by up to 30 percent, and one of their blood pressure numbers (the systolic blood pressure) dropped by 21 percent. By comparison, the people in the study who did not drink the juice had an increase in plaque thickness of 9 percent.
Again, the downside here is that this is a small study. However, it seems to correlate with the results found above, and I think it is worth pursuing further — especially since pomegranate juice costs about $5 at the store. Who knows, it may even save our financially strained health-care system a few dollars if it turns out to work as well as it seems to in these studies.
Some think that pomegranate helps plaque buildup by lowering cholesterol. But the jury is still out. One study say "yes," and another says "no." So, most likely, pomegranate helps circulation by another mechanism.
Although it isn't entirely clear yet, pomegranate juice may work because it is a good antioxidant. This may help the type of cholesterol that goes into the plaque to be less irritating to the artery wall, which could cause less plaque to form. Also, pomegranate helps increase the amount of a compound called "nitric oxide" which helps to open up blood vessels.
If you are going to try pomegranate juice, go for the long haul; you probably need to use it for at least one year to reap the benefits. As I mentioned in the last article, for those who prefer to use the juice concentrate instead of the juice itself to avoid some of the calories, that is probably fine. There is no proof at this point that capsules have the same effect as the juice itself.
Dr. Astrid Pujari is a Seattle M.D. with an additional degree as a medical herbalist; she practices at the Pujari Center and teaches as part of the residency programs at Virginia Mason and Swedish/Cherry Hill hospitals. Send questions to apujari@seattletimes.com for possible use in future columns. All information is intended for education and not a substitute for medical advice. Consult your doctor before following any suggestions given here.
Copyright © 2007 The Seattle Times Company
On the left hand, answers aren't easy
Getting active outside can bring sunshine to your winter
How to encourage healthy computing
Obese people asked to eat fast food for health study
Charlie Sheen claims AA has a 5 percent success rate — is he right?

general classifieds
Garage & estate salesFurniture & home furnishings
Electronics
just listed
American Bulldog pups NKC
Martin Logan speakers
Pug puppies ready for good homes
More listings
POST A FREE LISTING
- Lakewood cop accused of embezzling $150K meant for slain officers' families
- 3 big health insurers stockpile $2.4 billion as rates keep rising
- Agency set to investigate handling of 911 call about Josh Powell
- Quick decisions: How Washington hired its new football staff
- Historic day for gay marriage as another fight looms
- Justin Wilcox's versatile defensive style is the right fit for Huskies | Jerry Brewer
- It's Terrence Time: Enigmatic Ross leads Huskies
- Social worker recounts minutes before Powell fire
- $25B settlement reached over foreclosure abuses
- Club promoter convicted in brutal 2010 murder of Des Moines prostitute
- Gay-marriage bill passes House, awaits Gregoire's signature
459 - Historic day for gay marriage as another fight looming
352 - Wanted in Seattle classrooms: more teachers of color
242 - 3 big health insurers stockpile $2.4 billion as rates keep rising
239 - Source: NY, California to sign mortgage settlement
228 - Oregon live game thread
155 - Pac-12 picks ... including the UW game
140 - Council members get briefing on arena proposal, minus details
104 - Worker: Josh Powell told son he had 'surprise'
96 - AP Source: Obama to change birth control rule
88
- State Medicaid program to stop paying for unneeded ER visits
- 3 big health insurers stockpile $2.4 billion as rates keep rising
- Wanted in Seattle classrooms: more teachers of color
- One man's audacious pursuit of sailing history
- Darren Berg gets 18-year sentence for Ponzi scheme
- $25B settlement reached over foreclosure abuses
- Economy, blogs give survivalists new reason to look to Northwest
- 'Gauguin and Polynesia': dazzling mix-and-match | Art review
- State's share of mortgage settlement: $648 million
- A wandering gene's destructive path | Book review

